Even the most promising triage tests (CRP, host transcriptome signatures) have specificity limitations, since other conditions (viral infections, cancers) can produce readouts that may resemble TB,95 which impact implementation potential given that triage test specificity is the primary cost driver.96 This evidence concerns the gene CRP and tuberculosis.